Announcer:
������������������ From the National
Institutes of Health, in Bethesda, Maryland, this is All About Grants.
David
Kosub: ��������������� Hello, and welcome
to another edition of NIH's All About Grants podcast. I'm your host David Kosub
with the NIH office of extramural research. All right, so you've spent many
months working with your institution on developing an application seeking NIH support.
You're likely aware that the next step is for NIH to empanel a group of experts
to evaluate your application's scientific merit and provide us a score for
which we can use, consider to use for making funding decisions. But did you
know that there's another round of review that your application must go through
before we finally award? And that's what brings us here today, we're gonna talk
about the second round of peer review. We have with us Doctor Sally Amero, she�s
the NIH's review policy officer, and we also have Doctor Rebekah Rasooly, who
is a branch chief in program at the National Institute of Nursing research. So,
let's jump right in, Sally, can you briefly describe the two-tier NIH peer
review process, and how advisory councils fit in?
Dr.
Sally Amero: ����������� Sure, thank you
David. The two-stage peer review process for NIH is mandated by the public
health service act, that means that with limited exceptions, an application
must be recommended by both levels of peer review, initial peer review, and advisory
council review, in order for the NIH to make an award. In the first level of
peer review, applications are evaluated for scientific merit, in the second
level of peer review, what we call council review, that is perform by NIH,
national advisory councils or boards. They make recommendations on which
applications too fund, as well as priority areas of research and pending
policy.
David
Kosub: ��������������� And who exactly
sits on councils and how are they selected, or are they same folks that are in
the study section?
Dr.
Sally Amero: ����������� So, council
members are both scientific experts and public representatives, who are chosen
for their expertise, interest, or activity in matters related to health and
disease. Appointed members usually serve a four-year term, or in NCI a six-year
term.
David
Kosub: ��������������� Great, and just to
clarify, even if an application scores exceptionally well during the first
round of review, it still has to go through the second round?
Dr.
Sally Amero: ����������� Yes, that�s
correct.
David
Kosub: ��������������� Okay great, I also
think it's important to reiterate that, as we just mentioned during the first
two rounds of peer review, they provide funding recommendations for us to
consider, but it's up to the discretion of the director of the specific funding
institute or center to actually make, or whether or not to make an award. Rebekah,
turning to you, you've experienced a lot of these advisory councils up close
and personal, can you give us a little bit of your experience at NINR, how
these councils generally work?
Dr.
Rebekah Rasooly: � Well, advisory council
meetings have two parts. Much of the meeting is what's called an open session,
meaning it's open to members of the public, and it's intended to inform the
council about important NIH wide, and institute specific issues, and changes.
The council members of an institute's council are ambassadors who convey
significant information about NIH back to their respective research
communities. Now councils do not discuss every single submitted application.
Instead, when they discuss applications, they discuss a small subset of them,
and that discussion happens in what's called the closed session, and there they
typically discuss applications that require council input for some specific
reason, such as a foreign application or an appeal. Each council follows the
procedures that were setup by the institute or center, and those procedures
outline which applications will be discussed.
David
Kosub: ��������������� That's very
interesting, you mentioned the closed sessions, you briefly discussed a little
bit about that, can you dive into that just a bit more?
Dr.
Rebekah Rasooly: � Well, in general I
think it's important to know that council discussions tend to remain at a very
high level in the closed session, and do not engage in detailed scientific
re-review of applications. So, for example, it's if an appeal of an initial
peer review that they're discussing, the council will discuss the appeal
letter. If there is an application involving an investigator who already has
substantial funding, that is to say, more than one million dollars in active
grants, the council will look for overlap in already funded applications, and
that helps us manage resources efficiently, at NIH. If an application asks for
more than 500,000 per year of direct costs, the council might be charged with
considering its relevance to IC, the institute or center's mission, the
potential value of the knowledge to be gained, and the complimentarily with
other supported research activities. Sometimes councils consider foreign applications
in their discussions, and there they discuss whether the application represents
a unique research opportunity. If the council is considering applications that
would be funded out of priority score order, or ones that the IC wants to skip
within the priority score order, then the council will typically focus on the
public health relevance of the application, and how it fits into the portfolio
balance of the funding institute, or center.
David
Kosub: ��������������� Okay great, can you
also go a little bit further into the general decision-making processes that
they make, perhaps even using your experiences at NINR?
Dr.
Rebekah Rasooly: � So, in a typical
situation, in the closed session, when the council is discussing one of the
small number, specific applications. Two or more council members will be
assigned to the application in question, and they will present their opinions.
And then the remaining members or council are invited to discuss the
application. Often, I would say, there's really excellent consensus among the
members. I wanted to say that at NINR council one of the categories of
applications that are brought are those in the funding, when the study section has
identified human subjects� concerns, and it's very interesting at NIRN council
to hear the voices of the members, most of whom were, or still are practicing
nurses. When they comment on human subjects and research, and they have such
insightful views, which are invariable informed both by policy as well as by
their personal expertise.
David
Kosub: ��������������� Going a little
further, some of our listeners may have heard about expedited council review,
can you briefly describe what that means?
Dr.
Rebekah Rasooly: � So that refers to the
fact that most applications are not discussed individually at council meetings.
Only that small subset that fall into specific categories identified in council
procedures are actually discussed. For the remaining applications, the councils
generally consider them as a group, and vote to concur with the study section
recommendation as a single expedited action.
David
Kosub: ��������������� Fantastic, and
Sally, turning to you for some final thoughts, do you have anything that you'd
like to leave with our listeners regarding the second round of council review?
Dr.
Sally Amero: ����������� Well sure, both
levels of NIH peer review strive to seek and maintain the highest standards of
excellence. Both stages tend to promote a fair equitable and timely framework
for our funding decisions. Each institute or center has the responsibility of
selecting meritorious applications for payment. Whether by establishing a pay
line or by priority criteria. The second level of review by council provides
crucial input during this process, especially on the small number of
applications where specific council relevant issues need to be discussed.
However, council review is just advisory, and funding decisions are not made at
council meetings or by council members.
David
Kosub: ��������������� Fantastic, thank
you very much Sally and Rebecca, I truly appreciate this opportunity to speak
to you both about the second round of review here at the NIH. This is David
Kosub with NIH's All About Grants, thank you.
Announcer:
������������������ For more information on
the second round of review at NIH, please visit the office of extramural
research�s webpage at grants.nih.gov/grants/peer-review.htm. Once again that's
grants.nih.gov/grants/peer-review.htm